Viewing nowPregabalin Capsules 25 mg
Pregabalin 25mg
Hard capsule · Prescription medication
Genupharm Co., Ltd.

MFDS item code 201906161 · Approved 2019.08.29 · Insurance code 698004150
Treatment of peripheral and central neuropathic pain, adjunctive treatment for partial seizures in epilepsy, improvement of fibromyalgia.
This medication is used to treat peripheral and central neuropathic pain in adults. It is also used as an adjunctive treatment for partial seizures in patients with epilepsy, regardless of the presence of secondary generalized symptoms. Additionally, it is effective in the treatment of fibromyalgia. In other words, it helps alleviate pain, control seizures, and improve muscle pain.
This medication is administered orally, divided into two doses per day without regard to meals. 1. Neuropathic pain - Peripheral neuropathic pain: Starting dose is 150 mg per day, can be increased to 300 mg per day within 3 to 7 days; if necessary, can be increased to a maximum of 600 mg per day at intervals of 7 days. - Central neuropathic pain: Starting dose is 150 mg per day, can be increased to 300 mg after 1 week.
There is insufficient safety and efficacy data for children under 12 years and adolescents aged 12-17, so administration is not recommended.
This medication may increase the risk of suicidal thoughts or behaviors; thus, any changes in mood or symptoms of depression during administration should be reported to a healthcare professional immediately. Do not use this medication if you are allergic to it or have certain genetic conditions such as lactose intolerance. Diabetes patients may need to adjust their blood sugar medication dosage as weight gain after taking this medication can affect blood sugar control. If symptoms of angioedema, such as swelling of the face or neck, occur during treatment, discontinue use immediately and consult a healthcare professional. Elderly patients should be cautious as dizziness or drowsiness may increase the risk of falls or accidents. Transient visual disturbances or changes in vision may occur and these symptoms may improve after discontinuation of the medication. Sudden cessation of this medication may lead to withdrawal symptoms including insomnia, headaches, nausea, and anxiety; therefore, it should be reduced gradually in consultation with a healthcare provider. Caution is required when taking this medication with others that affect the central nervous system due to an increased risk of drug abuse or dependency. Dosing adjustments may be necessary for patients with impaired renal function. Patients with heart diseases or congestive heart failure should be closely monitored while using this medication. Caution is also necessary when taking this medication with opioid analgesics as it can increase central nervous system depressant effects, resulting in a risk of respiratory depression. During early pregnancy, this medication may affect the fetus; it should be avoided during pregnancy, and effective contraception should be used by women of childbearing age. During breastfeeding, this medication may be transmitted through breast milk, and should be discussed with a healthcare professional to consider stopping the drug or breastfeeding. It is advisable to avoid dangerous activities such as driving or operating machinery until dizziness or drowsiness has subsided after taking this medication. If severe rashes or blisters appear on the skin during treatment, discontinue use immediately and inform a healthcare professional. In case of overdose, symptoms such as confusion, drowsiness, and depression may occur, necessitating immediate medical attention.
Hives, severe swelling (including angioedema symptoms), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, pain in the mucous membranes of the mouth/eyes, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy throughout the body, sudden and severe headache, thunderclap headache, seizures, confusion of consciousness, visual disturbances.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture; therefore, it should be stored in a tightly closed container. It is best kept at room temperature between 15 to 30 degrees Celsius. This will help maintain the effectiveness of the medication for a longer period.
A hard capsule with a light yellow upper part and a white lower part containing white powder.
30 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 25mg
Hard capsule · Prescription medication
Genupharm Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.